![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Atlas Copco (PK) | USOTC:ATLKY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.19 | 1.02% | 18.87 | 18.62 | 18.95 | 18.87 | 18.59 | 18.59 | 63,714 | 21:04:15 |
By Kathryn Hardison
International stocks trading in New York closed lower on Wednesday.
The S&P/BNY Mellon index of American depositary receipts fell 1.5% to 123.98. The European index decreased 1.5% to 121.93, the Asian index fell 1.3% to 135.92, the Latin American index dropped 3% to 185.64 and the emerging markets index decreased 1.7% to 234.02.
Novo Nordisk AS and Atlas Copco AB were among the companies with ADRs that traded actively.
ADRs of Novo Nordisk increased 7.4% after the Danish pharmaceutical company raised its full-year guidance and reported a third-quarter net profit that beat expectations. The company said it saw strong demand for its diabetes care and obesity treatments in the latest quarter. The company now expects full-year sales growth of 14% to 17%, up from its prior outlook of 12% to 16% growth.
ADRs of Atlas Copco fell 1.9% after the Swedish industrial tool maker said its Edwards subsidiary will build a manufacturing facility in western New York for dry vacuum pumps used to make semiconductors. The investment will be roughly $319 million over the next seven years.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
November 02, 2022 18:19 ET (22:19 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Atlas Copco (PK) Chart |
1 Month Atlas Copco (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions